Hybrid Closure of Congenital Heart Disease

NCT02794584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Ventricular Septal Defects

Interventions

DRUG: sufentanil anesthesia
PROCEDURE: Hybrid closure
PROCEDURE: Control

Sponsor

Nanjing Medical University